MAJOR WORLD MARKETS FOR STENTS - TF Market Research

The Premium Business Information Source™

TF Market Research

Title:	MAJOR WORLD MARKETS FOR STENTS
Price:	$3,980.00
Publication Date:	May 01, 2008
Source:	KALORAMA INFORMATION
Brief Excerpt:	...Copyright #### Kalorama Information Reproduction without prior wr itten permission, in any media now in ex istence or hereafter developed, in whole or in any part, is strictly prohibited. ...
Length:	210 Pages (199 Billable Pages)
Geographic Region:	MULTINATIONAL
Industry:	MEDICAL SUPPLY
Non-Billable Page Numbers:	1;2;3;4;5;6;7;8;9;10;28
Format:	Adobe Acrobat

Sections
	Title	Starting Page	Number of Pages
	Disclosure	3	1
	CHAPTER ONE	11	1
	Executive Summary	11	1
	BACKGROUND	11	5
	W 200	13	1
	SCOPE AND METHODOLOGY	16	2
	SIZE AND GROWTH OF MARKET	17	11
	201	19	1
	and 2	20	1
	2013 an	21	1
		22	1
	Mark	23	1
	Ma	24	1
	CHAPTER TWO	29	1
	Overview: Cardiovascular Disease and Coronary Stents	29	1
	BACKGROUND	29	16
	Co 200	31	1
	W 200	38	1
	STENTS, COATINGS AND SUBACUTE THROMBOSIS	45	2
	DRUG ELUTING STENT TECHNOLOGY	47	14
	ALTERNATIVES TO DRUG-ELUTING STENTS	60	5
	CHAPTER THREE	65	1
	The Economics Of Coronary Stents	65	24
	CHAPTER FOUR	89	1
	Market Summary	89	6
	DEMOGRAPHICS	94	26
	200	110	1
	Deat	115	1
	of De	116	1
	PUBLIC HEALTH ISSUES	119	46
	(Millions	146	1
	(Mill	147	1
	2008-2018 (Mi	148	1
		149	1
	Mark	150	1
	M	151	1
	CHAPTER FIVE	165	1
	Company Summaries	165	1
	OVERVIEW	165	1
	ABBOTT VASCULAR (DIVISION OF ABBOTT LABORATORIES)	166	1
	Key Coronary Stent Products:	166	1
	Summary	166	35
	ATRIUM MEDICAL CORPORATION	169	1
	Key Coronary Stent Products:	169	1
	BOSTON SCIENTIFIC	171	1
	Key Coronary Stent Products:	171	1
	CELONOVA BIOSCIENCES	174	1
	Key Coronary Stent Products:	174	1
	CONOR MEDSYSTEMS (A JOHNSON & JOHNSON COMPANY)	176	1
	Key Coronary Stent Products:	176	1
	CORDIS CORPORATION (A JOHNSON & JOHNSON COMPANY)	179	1
	Key Coronary Stent Products:	179	1
	MEDINOL LTD.	182	1
	Key Coronary Stent Products:	182	1
	MEDTRONIC, INC.	184	1
	Key Coronary Stent Products:	184	1
	MIV THERAPEUTICS, INC.	188	1
	Key Coronary Stent Products:	188	1
	ORBUSNEICH	191	1
	Key Coronary Stent Products:	191	1
	STENTYS S.A.S.	194	1
	Key Coronary Stent Products:	194	1
	TERUMO MEDICAL CORPORATION	196	1
	Key Coronary Stent Products:	196	1
	XTENT, INC.	198	1
	Key Coronary Stent Products:	198	1
	CHAPTER SIX	201	1
	Conclusions and Strategic Implications	201	1
	FIRST CONCLUSION	201	2
	SECOND CONCLUSION	202	2
	THIRD CONCLUSION	204	2
	FOURTH CONCLUSION	205	2
	FIFTH CONCLUSION	206	2
	SIXTH CONCLUSION	207	2
	SEVENTH CONCLUSION	208	2
	EIGHTH CONCLUSION	209	1
	NINTH CONCLUSION	209	2
Tables
	Title	Starting Page	Number of Pages
	1 Top Ten Major Causes of Death in the World By Region	30	1
	3 Top Ten Major Causes of Death in the World By Income Level: 2001	32	2
	1 Economic Burden (Direct Costs) of Restenosis (*)	68	1
	2 Medicare Trends in Coronary Revascularization Therapy: 1998-2001	72	1
	3 Cost Per Repeated Revascularization Avoided	79	1
	4 Willingness to Pay for Restenosis Prevention Technology	80	1
	5 Predicted Clinical Restenosis Rates Following PTCA and Stent	82	1
	6 Expected Cost-Effectiveness of Drug-Eluting Stents	83	1
	1 IHD/CHD Heart Disease Age-Standardized Mortality Rates (*) for Both Sexes	91	1
	2 Projected Populations of the Seven Major World Markets: 2008-2018 (Millions)	96	1
	3 Ranking of the Major Causes of Death by Age Group in the United States: 2003	101	1
	4 Trends in the Older (60+) Populations of the Seen Major World Healthcare Markets: 1950-2050 (Millions)	102	1
	5 Increases in IHD/CHD Incidence (*) with Age	105	1
	6 Crude Death Rates (*) Associated with CVD: 2004	107	1
	7 Crude Death Rates (*) Associated with IHD/CHD: 2006	108	1
	9 Death Rates (*) for CVD for Men by Race and Ethnicity in the United States: 1985-2002	112	1
	10 Death Rates (*) for CVD for Women by Race and Ethnicity in the United States: 1985-2002	113	1
	13 Deaths from CVD for White and Black Men in the United States by Age Group: 2004	117	1
	14 Deaths from CVD for White and Black Women in the United States by Age Group: 2004	117	1
	15 Percentage of Obesity in the Seven Major World Healthcare Markets: 2005	120	1
	16 Prevalence of Obesity in the Seven Major World Healthcare Markets: 2004	121	1
	17 Smoking Prevalence in the Seven Major World Healthcare Markets (Standardized Data - % of Population)	126	1
	18 Cost Estimates of Revascularization Using Drug-Eluting Stents versus Bare Metal Stents: 2003	133	1
	Company Data	166	1
	Recent Revenue History: (US$ Millions)	166	1
	Company Data	169	1
	Recent Revenue History:	169	1
	Company Data	171	1
	Recent Revenue History:	171	1
	Company Data	174	1
	Recent Revenue History:	174	1
	Company Data	176	1
	Recent Revenue History:	176	1
	Company Data	179	1
	Recent Revenue History:	179	1
	Company Data	182	1
	Recent Revenue History:	182	1
	Company Data	184	1
	Recent Revenue History:	184	1
	Company Data	188	1
	Recent Revenue History:	188	1
	Company Data	191	1
	Recent Revenue History:	191	1
	Company Data	194	1
	Recent Revenue History:	194	1
	Company Data	196	1
	Recent Revenue History:	196	1
	Company Data	198	1
	Recent Revenue History:	198	1
Graphs
	Title	Starting Page	Number of Pages
	Figure 2-1 Percentages Of Deaths Related To Cardiovascular Diseases In The Seven Major World Healthcare Markets: 2001	36	1
	Figure 2-2 Distribution of Projected Ischemic Heart Disease Fatalities in the Seven Major World Healthcare Marke 2008	39	1
	Figure 2-3 Distribution of Projected Acute Myocardial Infarction Fatalities in the Seven Major World Healthcare 2008	40	1
	Figure 3-1 Projected Two-Year Cardiovascular Cost Impact Of Background Restenosis Rate	74	1
	Figure 3-2 Cost Per Quality-Adjusted Year Of Life Saved For Some Healthcare Investments: Preventive And Therapeutic	77	1
	Figure 4-1 Projected IHD/CHD Cases: 2008	92	1
	Figure 4-2(A) Trending In The Populations Of The Five Major European Healthcare Markets: 2008-2018	99	1
	Figure 4-2(B) Trending In The Populations Of Japan And The United States: 2008-2018	100	1
	Figure 4-3 Trending In The 60+ Year Old Population Of The Seven Major World Healthcare Markets: 1950-2050	103	1
	Figure 4-4 Trending in the Percentage of the General Population that is 60+ Years Old in the Seven Major Wo 1950-2050	104	1
	Figure 4-5 Trending in the Percentage Differences in CVD Deaths of Black Men and Women over those of White Men a 2004	118	1
	Figure 4-6 Age-Adjusted Prevalence Of Obesity (*) In Adult Americans (Ages 20 To 74) By Sex: 1960-2004	123	1
	Figure 4-7 Prevalence Of Hypertension In Americans Age 20 Years And Older By Age And Sex	129	1
	Figure 4-11 Estimated Coronary Stent Market Average Annual Growth Rates in the Seven Major World Healthcare 2008-2018	152	1
	Figure 4-12 Distribution of the Estimated Total Market for Coronary Stents in the Seven Major World Healthc 2008-2018	153	1

Enter the keyword(s) which you would like to search for within this document and click "Search"



Price: $3,980.00

Looking For Something Else?

Search the Alacra Store

TF Market Research® reports contain in-depth primary research and statistics, market trends, forecasts, segment analysis and much more from over 100 top con sulting, market research and business publishing sources. The service is updated daily.

about us

public company index

private company index

Copyright © 2008 Alacra, Inc., 100 Broadway, Suite 1100, New York, NY 10005. All rights reserved.
Reproduction in whole or in part in any form or medium without express written permission is prohibited.